Vasista, A., Martin, A., Pavlakis, N., Sjoquist, K. M., Snow, S., Jonker, D., … Kiely, B. (2017). Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in A Randomised Phase II Trial of Regorafenib in Advanced Gastric Cancer. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (Vol. 13, pp. 138–138). WILEY.

Vasista, Anuradha, Andrew Martin, Nick Pavlakis, Katrin M. Sjoquist, Stephanie Snow, Derek Jonker, Yu Jo Chua, et al. “Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in A Randomised Phase II Trial of Regorafenib in Advanced Gastric Cancer.” In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 13:138–138. WILEY, 2017.

Vasista A, Martin A, Pavlakis N, Sjoquist KM, Snow S, Jonker D, et al. Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in A Randomised Phase II Trial of Regorafenib in Advanced Gastric Cancer. In: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY; 2017. p. 138–138.

Vasista, Anuradha, et al. “Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in A Randomised Phase II Trial of Regorafenib in Advanced Gastric Cancer.” ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol. 13, WILEY, 2017, pp. 138–138.

Vasista A, Martin A, Pavlakis N, Sjoquist KM, Snow S, Jonker D, Chua YJ, Epstein R, Bonaventura T, Khasraw M, Varma S, Singhal N, Ransom D, Aubin F, Burkes R, Lim H, Lemay F, Begbie S, Stockler M, Kiely B. Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in A Randomised Phase II Trial of Regorafenib in Advanced Gastric Cancer. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY; 2017. p. 138–138.